- Home
- CTSO vs DGHI Comparison
CTSO vs DGHI Comparison
Compare CTSO & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- DGHI
- Stock Information
- Founded
- CTSO 1997
- DGHI 2017
- Country
- CTSO United States
- DGHI United States
- Employees
- CTSO N/A
- DGHI N/A
- Industry
- CTSO Medical/Dental Instruments
- DGHI Finance: Consumer Services
- Sector
- CTSO Health Care
- DGHI Finance
- Exchange
- CTSO Nasdaq
- DGHI Nasdaq
- Market Cap
- CTSO 51.6M
- DGHI 61.7M
- IPO Year
- CTSO N/A
- DGHI N/A
- Fundamental
- Price
- CTSO $1.03
- DGHI $2.22
- Analyst Decision
- CTSO Strong Buy
- DGHI Strong Buy
- Analyst Count
- CTSO 3
- DGHI 1
- Target Price
- CTSO $4.67
- DGHI $2.50
- AVG Volume (30 Days)
- CTSO 538.8K
- DGHI 305.5K
- Earning Date
- CTSO 03-06-2025
- DGHI 11-15-2024
- Dividend Yield
- CTSO N/A
- DGHI N/A
- EPS Growth
- CTSO N/A
- DGHI N/A
- EPS
- CTSO N/A
- DGHI N/A
- Revenue
- CTSO $37,739,531.00
- DGHI $42,146,057.00
- Revenue This Year
- CTSO $9.20
- DGHI N/A
- Revenue Next Year
- CTSO $11.64
- DGHI N/A
- P/E Ratio
- CTSO N/A
- DGHI N/A
- Revenue Growth
- CTSO 1.80
- DGHI 100.56
- 52 Week Low
- CTSO $0.70
- DGHI $0.84
- 52 Week High
- CTSO $1.59
- DGHI $2.34
- Technical
- Relative Strength Index (RSI)
- CTSO 55.82
- DGHI 66.00
- Support Level
- CTSO $1.00
- DGHI $1.41
- Resistance Level
- CTSO $1.14
- DGHI $1.74
- Average True Range (ATR)
- CTSO 0.09
- DGHI 0.18
- MACD
- CTSO 0.01
- DGHI 0.05
- Stochastic Oscillator
- CTSO 64.40
- DGHI 87.10
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About DGHI Digihost Technology Inc. Common Subordinate Voting Shares
Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.